Physician

Laura M Robert, MD

According to 2025 Medicare claims, Laura Robert, MD (NPI: 1235111899) practices family practice in the Lynchburg, VA market, with the plurality of this provider's patient population coming from Lynchburg City, VA. This provider's primary affiliated billing organization is PRIVIA MEDICAL GROUP, LLC (NPI: 1013042480; TIN: 202265068) and primary practice location at 24551-4662. Robert is affiliated with the Privia Quality Network, LLC (ACO ID: A2057), participating under the MSSP model.

Robert's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 373 traditional Medicare patients, billed 9,711 HCPCS/CPT codes, and received $238,157 in Medicare payments. The top billing code was 80061 (Blood test, lipids (cholesterol and triglycerides)). Part D data shows 7,489 prescription claims across 496 beneficiaries totaling $589,220 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 397 claims. Open Payments data shows 89 records totaling $1,589. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $127,338 to $238,157. Similarly, Part D prescription costs have risen steadily, from $334,485 to $589,220. In contrast, DME billing represents a smaller volume and did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	305	4,938	$127,338
2016	296	5,349	$129,332
2017	330	5,814	$152,973
2018	310	5,951	$154,008
2019	321	6,285	$153,623
2020	309	6,749	$163,675
2021	311	6,665	$182,267
2022	300	6,621	$169,202
2023	370	6,980	$186,079
2024	373	9,711	$238,157

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	265	5,414	$334,485
2016	295	5,657	$288,865
2017	306	6,237	$317,644
2018	321	6,369	$328,327
2019	357	6,355	$389,741
2020	357	6,514	$449,600
2021	368	6,342	$478,816
2022	391	6,409	$495,628
2023	393	6,548	$602,677
2024	496	7,489	$589,220

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	77	370	$16,435
2016	82	377	$10,916
2017	80	396	$9,466
2018	56	329	$7,583
2019	63	347	$7,640
2020	58	317	$9,419
2021	57	320	$14,964
2022	89	369	$13,502
2023	43	271	$15,029
2024	88	397	$17,216

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
80061	Blood test, lipids (cholesterol and triglycerides)	254	424	$13
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	268	475	$12
36415	Insertion of needle into vein for collection of blood sample	298	665	$9
80048	Blood test, basic group of blood chemicals (calcium, total)	250	431	$8
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	255	453	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	60	3,800	$68,657
Trulicity	Dulaglutide	51	1,960	$65,843
Ozempic	Semaglutide	55	2,226	$65,624
Jardiance	Empagliflozin	26	1,470	$28,565
Januvia	Sitagliptin Phosphate	20	1,510	$27,311

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	12	$5,656
A7032	Cushion for use on nasal mask interface, replacement only, each	N	N/R	26	$2,032
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	59	$1,886
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	15	35	$1,805
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	14	$1,081

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	89	$1,589	Novo Nordisk Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laura M. Robert, MD?

Tedicare shows public-source Medicare data for Laura M. Robert, MD (NPI 1235111899), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura M. Robert, MD have ACO affiliation data?

Laura M. Robert, MD is shown with ACO affiliation data for Privia Quality Network, LLC (MSSP, ACO ID A2057).

What billing organization is linked to Laura M. Robert, MD?

Laura M. Robert, MD is linked to PRIVIA MEDICAL GROUP, LLC (billing NPI 1013042480) in the available physician profile data.

Does Laura M. Robert, MD have Open Payments data?

Laura M. Robert, MD has 89 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.